Mesoblast (MESO) EPS (Weighted Average and Diluted): 2014-2023
Historic EPS (Weighted Average and Diluted) for Mesoblast (MESO) over the last 4 years, with Jun 2023 value amounting to -$0.19.
- Mesoblast's EPS (Weighted Average and Diluted) rose 22.10% to -$0.19 in Q2 2023 from the same period last year, while for Jun 2023 it was -$0.38, marking a year-over-year increase of 91.32%. This contributed to the annual value of -$0.08 for FY2025, which is 5.05% up from last year.
- As of Q2 2023, Mesoblast's EPS (Weighted Average and Diluted) stood at -$0.19, which was down 843.87% from $0.03 recorded in Q1 2023.
- In the past 5 years, Mesoblast's EPS (Weighted Average and Diluted) registered a high of $0.03 during Q4 2021, and its lowest value of -$4.22 during Q4 2020.
- In the last 3 years, Mesoblast's EPS (Weighted Average and Diluted) had a median value of $0.02 in 2023 and averaged -$0.05.
- Per our database at Business Quant, Mesoblast's EPS (Weighted Average and Diluted) plummeted by 245.90% in 2020 and then soared by 100.83% in 2021.
- Over the past 5 years, Mesoblast's EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.22 in 2019, then crashed by 245.90% to -$4.22 in 2020, then surged by 100.83% to $0.03 in 2021, then crashed by 33.71% to $0.02 in 2022, then increased by 22.10% to -$0.19 in 2023.
- Its EPS (Weighted Average and Diluted) was -$0.19 in Q2 2023, compared to $0.03 in Q1 2023 and $0.02 in Q4 2022.